← Leaderboards
Kanta Subbarao
University Of California Davis
$14,152
Attributed
$14,152
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$14,152 · 1
By mechanism
P51$14,152 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Neutralizing Antibody”
- Barton F Haynes · Duke University$361,488,167
- Dennis R. Burton · Scripps Research Institute$328,455,703
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$262,392,049
- Lawrence Corey · Fred Hutchinson Cancer Center$257,355,255
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$139,509,763
Research focus
Neutralizing AntibodyLaboratory MouseFerretsTissue /Cell CultureVaccine DevelopmentVirusGenesImmunogenicityEvaluationEpidemicProphylactic TreatmentSerumInflammationVaccinesImmunotherapyInfectionLungCross ReactivityDisease OutbreaksAttenuatedScientistExhibitsImmune ResponseAntibodies
Grant awards (12)
Preclinical Studies of Vaccines for Pandemic Influenza$1,896,554
Z01 · FY2008 · AI · contact PI
Vaccines, Immunoprophylaxis, and Immunotherapy for SARS$306,045
Z01 · FY2008 · AI · contact PI
Preclinical Studies of Vaccines for Pandemic Influenza$2,549,552
Z01 · FY2007 · AI · contact PI
Vaccines, Immunoprophylaxis, and Immunotherapy for SARS$1,581,212
Z01 · FY2007 · AI · contact PI
Vaccines for Pandemic Influenza$0
Z01 · FY2006 · AI · contact PI
Vaccines, Immunoprophylaxis, and Immunotherapy for SARS$0
Z01 · FY2006 · AI · contact PI
Vaccines for Pandemic Influenza$0
Z01 · FY2005 · AI
Vaccines, Immunoprophylaxis, and Immunotherapy for SARS$0
Z01 · FY2005 · AI
Vaccines, Immunoprophylaxis, and Immunotherapy for SARS$0
Z01 · FY2004 · AI
EVAL. OF VACCINE AGAINST HIGHLY PATHOGENIC INFLUENZA A(H5N1) VIRUS IN MACAQUES$14,152
P51 · FY2003 · RR
Vaccines for Pandemic Influenza$0
Z01 · FY2003 · AI
Vaccines, Immunoprophylaxis, and Immunotherapy for SARS$0
Z01 · FY2003 · AI